| Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, today announced that it has secured £3.5m in new equity financing, including £2.5m from lead investor |
Everton... semulov skaeps tca sselfles s'Meth,... srotucesorP :diaR esuoH DPJ nICanada... 'gnileef tsroW' :renniw etal sCo-op... raey tsrif ni ymonoce lacol ehLTC... segatrohs dima egnahc rof daelThis... nioctiB rof regnahC emaG a eBSupreme... aixopyh negortin detsetnu yb dCrypto... tuo nekat B9.1$ retfa slawardhVarun... sklat edart SU ni ruobaL rof ’Ram... daB eht dna dooG ehT :OHR 0051